 |
|
| Personal data sheet |
 Print previewpersonal data approved: 2022. IV. 23. | Publications |
2019
 from data base, 2019. XII. 16. |
Pallagi Edina, Jojart-Laczkovich Orsolya, Nemeth Zsofia, Szabo-Revesz Piroska, Csoka Ildiko: Application of the QbD-based approach in the early development of liposomes for nasal administration, INTERNATIONAL JOURNAL OF PHARMACEUTICS 562: pp. 11-22.
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2018
from data base, 2019. XII. 16. |
Csóka Ildiko, Pallagi Edina, Paál Tamás L.: Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes, DRUG DISCOVERY TODAY 23: (7) pp. 1340-1343.
type of document: Journal paper/Review paper
number of independent citations: 4
language: English
URL |
2018
from data base, 2019. XII. 16. |
Edina Pallagi, Ruba Ismail, Tamás L Paál, Ildikó Csóka: Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 122: pp. 160-169.
type of document: Journal paper/Article
number of independent citations: 3
language: English
URL |
2018
from data base, 2019. XII. 16. |
Bartos C, Pallagi E, Szabó-Révész P, Ambrus R, Katona G, Kiss T, Rahimi M, Csóka I: Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 123: pp. 475-483.
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2017
from data base, 2019. XII. 16. |
Gieszinger P, Csoka I, Pallagi E, Katona G, Jojart-Laczkovich O, Szabo-Revesz P, Ambrus R: Preliminary study of nanonized lamotrigine containing products for nasal powder formulation, DRUG DESIGN DEVELOPMENT AND THERAPY 11: pp. 2453-2466.
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2016
from data base, 2019. XII. 16. |
Pallagi Edina, Karimi Keyhaneh, Ambrus Rita, Szabó-Révész Piroska, Csóka Ildikó: New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach, INTERNATIONAL JOURNAL OF PHARMACEUTICS 511: (1) pp. 151-160.
type of document: Journal paper/Article
number of independent citations: 9
language: English
URL |
2016
from data base, 2019. XII. 16. |
Karimi Keyhaneh, Pallagi Edina, Szabó-Révész Piroska, Csóka Ildikó, Ambrus Rita: Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach, DRUG DESIGN DEVELOPMENT AND THERAPY 10: pp. 3331-3343.
type of document: Journal paper/Article
number of independent citations: 8
language: English
URL |
2015
from data base, 2019. XII. 16. |
Pallagi Edina, Ambrus Rita, Szabó-Révész Piroska, Csóka Ildikó: Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation, INTERNATIONAL JOURNAL OF PHARMACEUTICS 491: (1–2) pp. 384-392.
type of document: Journal paper/Article
number of independent citations: 27
language: English
URL |
2007
from data base, 2019. XII. 16. |
Szuts A, Pallagi E, Regdon G, Aigner Z, Szabo-Revesz P: Study of thermal behaviour of sugar esters, INTERNATIONAL JOURNAL OF PHARMACEUTICS 336: (2) pp. 199-207.
type of document: Journal paper/Article
number of independent citations: 35
language: English
URL |
2004
from data base, 2019. XII. 16. |
Pallagi E, Vass K, Pintye-Hódi K, Kása P Jr, Erős I, Szabó-Révész P: Iron(II) sulfate release from drop-formed lipophilic matrices developed by special hot-melt technology, EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 57: pp. 287-294.
type of document: Journal paper/Article
number of independent citations: 5
language: English
URL |
| | Number of independent citations to these publications: | 94 |
|
|
|
|
|
Login
